Altasciences Featured Articles

  1. Scratching The Surface Of Nonclinical Dermal Testing 8/11/2025

    In this eBook, we answer critical questions and highlight key considerations to help you advance your dermal program from discovery through clinical trials to proof of concept, and beyond.

  2. Discovery Studies: An Agile Approach To Early Data For Quicker Decisions 8/6/2025

    This scientific journal explores the value and characteristics of discovery research and presents two case studies on biodistribution under specific experimental conditions.

  3. Studying The Effects Of Drugs On Driving 5/9/2025

    Discover how early clinical cognitive testing and dedicated driving simulation studies can help assess the cognitive functions for safety and efficacy in drug development.

  4. Navigating The Complexities Of CNS-Active Drugs 5/9/2025

    In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development.

  5. Psychedelics And Entactogens: Challenges Associated With Schedule 1 Therapeutic Development 5/9/2025

    Industry experts explore the regulatory challenges of Schedule 1 drug development, including required studies, specialized assessments, and key formulation and manufacturing considerations.

  6. Sinclair Nanopig™: Multi-Omics To Pharmacology And Toxicology 2/25/2025

    Consider the potential of Sinclair Nanopig™ as a next-generation non-rodent model to enhance drug development, improve regulatory pharmacology, and reduce reliance on traditional non-rodent models.

  7. Procedure For Repeated Ultrasound Guided Liver Biopsies In NHPs 2/25/2025

    Ultrasound-guided liver biopsies offer a safe, minimally invasive method for repeated tissue collection in non-human primates, ensuring reliable results with minimal animal stress and recovery time.

  8. The FDA Animal Rule And Standard For Exchange Of Nonclinical Data 2/25/2025

    Support the development of standardized SEND guidelines for Animal Rule studies to ensure accurate and consistent regulatory submissions for acute radiation syndrome research.

  9. LC-MS/MS Assay For CTI-1601 In Monkey Tissues: Disposition, Processing 2/25/2025

    A robust LC-MS/MS assay to quantify CTI-1601 in cynomolgus monkey tissues is essential for understanding its disposition and processing, supporting its potential as a protein replacement therapy.

  10. Translatability Of NHP Cytokine Data To In-Life Parameters In Toxicology Studies 2/25/2025

    For accurate immunotoxicity assessment, cytokine data should be interpreted alongside clinical observations, body weight, and clinical pathology parameters.